The incidence of invasive breast cancer after conservative treatment for ductal carcinoma in situ (DCIS) decreased by more than 50% over the past 30 years, data from a Dutch cancer registry showed.

SAN ANTONIO – For patients with “good-risk” ductal carcinoma in situ (DCIS) who underwent breast- conserving surgery and did not receive radiotherapy, tamoxifen significantly decreased the risk of ...

SAN ANTONIO – Among patients with hormone receptor (HR)-positive, HER2-negative, low-risk ductal carcinoma in situ (DCIS), those who underwent active monitoring had similar two-year invasive ...

Nonrandomized Comparison of Primary Chemotherapy and Retroperitoneal Lymph Node Dissection for Clinical Stage IIA and IIB Nonseminomatous Germ Cell Testicular Cancer Multifocality is a significant ...

October 27, 2009 — Women with low- to intermediate-grade ductal carcinoma in situ (DCIS) with margins 3 mm or wider had an "acceptably low rate" of ipsilateral breast events 5 years after excision ...

SAN ANTONIO -- Active monitoring for low-risk ductal carcinoma in situ (DCIS) did not lead to a higher rate of ipsilateral invasive cancer versus guideline-recommended treatment, the randomized COMET ...

Understand the key factors influencing breast cancer recurrence and discover effective treatments and lifestyle changes that ...

Recent data from US centers show that low-dose tamoxifen is the most popular choice of preventive therapy in women with high-risk lesions, with low discontinuation rates at 1 year compared with the ...

Study findings highlight the importance of follow-up screening and the value of patient communication among DCIS, or ductal carcinoma in situ, survivors. A study published in 2023 sheds light on how ...

In the UK, DCIS currently comprises 20% of screen-detected cancers. It is generally agreed that adequate local treatment comprises either simple mastectomy alone or complete microscopic tumour ...